Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Oral ZPL389 With Topical Corticosteroids/Calcineurin Inhibitors in Adult Atopic Dermatitis
jRCT2080224724Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of adriforant in atopic dermatitis (AD), sponsored by Novartis. Started Jun 2019; status: completed.
02
Drugs
adriforant
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2080224724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224724.